简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Guardant Health在United Health覆盖Shield测试后股价上涨

2026-07-01 23:36

  • Guardant Health (GH) is up ~7% in Wednesday morning trading after UnitedHealth Group (UNH) said it would cover the company's blood-based cancer screening test, Guardant Shield, starting Aug. 1.
  • The test is used to screen for colorectal cancer.
  • Citi analyst Patrick Donnelly said the move is "another positive catalyst for Shield as this expansion of the covered patient opportunity unlocks a new cohort of volumes and should drive significant ASP benefits."

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。